Outcome of complicated osteoarticular brucellosis in a tertiary care center in Saudi Arabia.

Ebrahim MahmoudAreej AlamanRaghad AlsayariAnadel HakeemMohammad BosaeedAzaheer IbrahimSaleh AlgazlanAbdullah AlmaneaAhmed A Abulaban

Published in: PloS one (2024)

Unfavorable outcomes have been noticed to be minimal in our cohort of patients with osteoarticular brucellosis, treated mainly with a three-drug regimen and a longer duration of therapy.

Keyphrases

tertiary care
adverse drug
metabolic syndrome
drug induced
newly diagnosed
mesenchymal stem cells
insulin resistance
electronic health record